1415999-92-6

Basic information

• Product Name: N-(5-(9-oxo-10-(3-(trifluoromethyl)phenyl)-9,10-dihydropyrido[3,2-c][1,5]naphthyridin-2-yl) pyridin-2-yl)acetamide
• Synonyms: N-(5-(9-oxo-10-(3-(trifluoromethyl)phenyl)-9,10-dihydropyrido[3,2-c][1,5]naphthyridin-2-yl) pyridin-2-yl)acetamide
• CAS NO: 1415999-92-6
• Molecular Weight: 475.43
• Mol File: 1415999-92-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(5-(9-oxo-10-(3-(trifluoromethyl)phenyl)-9,10-dihydropyrido[3,2-c][1,5]naphthyridin-2-yl) pyridin-2-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-(9-oxo-10-(3-(trifluoromethyl)phenyl)-9,10-dihydropyrido[3,2-c][1,5]naphthyridin-2-yl) pyridin-2-yl)acetamide(1415999-92-6)
• EPA Substance Registry System: N-(5-(9-oxo-10-(3-(trifluoromethyl)phenyl)-9,10-dihydropyrido[3,2-c][1,5]naphthyridin-2-yl) pyridin-2-yl)acetamide(1415999-92-6)

Safety Data

• Hazardous Substances Data: 1415999-92-6(Hazardous Substances Data)

Upstream product

• 1184919-05-8 ethyl 6-bromo-4-hydroxy-1,5-naphthyridine-3-carboxylate 
• 1220700-73-1 diethyl 2-(((6-bromopyridin-3-yl)amino)methylene)malonate 
• 13534-97-9 6-bromopyridine-3-amine 
• 1416000-52-6 ethyl 6-chloro-4-((3-(trifluoromethyl)phenyl)amino)-1,5-naphthyridine-3-carboxylate 
• 127094-57-9 4,6-dichloro-(1,5)-naphthyridine-3-carboxylic acid ethyl ester 
• 827614-64-2 2-aminopyridine-5-boronic acid pinacol ester 
• 904326-87-0 N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide 
• 1416000-57-1 2-chloro-10-(3-(trifluoromethyl)phenyl)pyrido[3,2-c][1,5]naphthyridin-9(10H)-one 
• 1416000-54-8 6-chloro-4-((3-(trifluoromethyl)phenyl)amino)-1,5-naphthyridine-3-carbaldehyde 
• 4487-59-6 2-bromo-5-nitropyridine 
• 1438413-72-9 C₁₆H₁₁ClF₃N₃O 

Relevant articles and documents

Pyridonaphthyridine PI3K/MTOR Dual Inhibitors and Preparation and Use Thereof

The present invention relates to a pyridonaphthyridine compound as represented by general formula (I), which has a dual PI3K and mTOR inhibition effect, and its pharmaceutically acceptable salt, stereoisomer and deuteride thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the specification; the present invention also relates to a method for preparing said compound, a pharmaceutical composition and a pharmaceutical formulation containing said compound, and uses of said compound in treating and/or preventing a proliferative disease and in the manufacture of a medicament for treating and/or preventing a proliferative disease.